2,889
Views
6
CrossRef citations to date
0
Altmetric
Coronavirus – Research Paper

Demographic factors associated with acceptance, hesitancy, and refusal of COVID-19 vaccine among residents of Sukkur during lockdown: A cross sectional study from Pakistan

ORCID Icon, , , &
Article: 2026137 | Received 15 Oct 2021, Accepted 04 Jan 2022, Published online: 01 Feb 2022

ABSTRACT

Background

The World Health Organization has identified vaccine hesitancy among one of the top 10 threats to global health. The ongoing COVID-19 pandemic has devastated global health with higher morbidities and mortality rates. Reducing vaccine hesitancy could achieve immunization. However, different sociodemographic conditions can also hamper these efforts in low- and middle-income countries. The objective of the present study was to assess the demographic factors associated with COVID-19 vaccine acceptance, hesitancy, and refusal among the general Pakistani population.

Methods

This cross-sectional study was conducted during the months of February–March 2021 during the pandemic. Sample size was 479. Snowball sampling strategy was used for data collection. Study questionnaires were distributed online using e-mail, twitter, Facebook, and WhatsApp.

Result

The overall COVID-19 vaccine acceptance was 40.5%, vaccine hesitancy was 29%, and vaccine refusal was 30% among the study participants. Compared to younger, the vaccine hesitancy and refusal was higher in older people age > 30 years (χ2 = 7.45, p = .02). Compared to males, vaccine refusal was high among females (χ2 = 7.45, p = .02). Vaccine refusal was higher in people with less educated <12 compared to more education (χ2 = 28.68, p < .0001).

Conclusion

Older people, females, and less education groups are at more risk of COVID-19 infections due to vaccine hesitancy and refusal. We recommend these groups should be focused in COVID-19 vaccine education programs.

Introduction

The ongoing COVID-19 pandemic was a result of SARS-CoV2 virus spread, which causes severe acute respiratory syndrome. COVID-19 was first identified in Wuhan, China, in November 2019.Citation1 Infection spread all over the world through infected travelers. On 11 March 2020, the World Health Organization (WHO) announced it as a global pandemic.Citation2 In the last 18 months, 152 million cases have been confirmed and more than 3 million people have died due to infection.Citation3 The countries including America, India, Brazil, Russia, and England are most affected in terms of COVID-19-related morbidity and mortality.Citation4 Until now, there is no specific treatment available for SARS-CoV2. However, several pharmaceutical companies, including Pfizer & BioNTech, Moderna, Gamaleya Scientific Institute, Novavax, AstraZeneca, Johnson, and Johnson and Sinovac, using new platforms have developed vaccines to prevent the COVID-19 infections among the population. Vaccine development is not an easy task. To launch a vaccine, there is a need to assess the efficacy and safety of the vaccine through clinical trials.Citation5 However, due to the severity of COVID-19 pandemic and to save humanity, several governments have approved emergency authorization use of vaccines in public to curtail the spread of new infections and reduce hospitalizations.

Despite the invention of vaccines against COVID-19, there is variability in vaccine acceptance among different countries.Citation6 The vaccine acceptance among the population depends on demographic factors such as age, gender, education, financial status, profession, ethnicity, living area type, and attitude and beliefs about the vaccine-related questions.Citation7,Citation8 The delay in accepting or refusing to vaccinate oneself is regarded as vaccine hesitancy. Now, COVID-19 vaccines are available in the markets. Three factors including (1) complacency (person perceives that there is low risk of exposure so no need to vaccinate), (2) convenience (Is vaccine available? Is it cost effective and in easy access?), and (3) confidence (Is the vaccine effective and safe?) are important to achieve full immunization.Citation9 Questions over the safety of the COVID-19 vaccine are in the debate.Citation5

South Asian countries including Pakistan, India, Bangladesh, Nepal, Bhutan, Afghanistan, and Maldives are demographically, religiously, and culturally diverse. These countries are facing problems such as income inequalities, rural–urban divide, low literacy rates, and health-related problems.Citation10 The prevalence of infectious diseases may vary among these countries. Despite facing such problems, countries including Bangladesh, Bhutan, India, Maldives, Nepal, and Sri Lanka were declared as polio-free countries by the WHO.Citation11 However, polio virus infections are still prevalent in Pakistan and Afghanistan. Religion-related narratives circulation electronic media also contribute in vaccine hesitancy.Citation12

Previously conducted studies on COVID-19 vaccine hesitancy show variability in vaccine acceptance across the countries. COVID-19 vaccine acceptance was 83%, 77%, 75%, and 68% in China, France, America, and Germany, respectively.Citation13–15 In predominantly Muslim countries, vaccine acceptance is much lower. For example a report by Sallam et al. has shown that vaccine acceptance in Kuwait and Jordan was 23% and 28%.Citation16 A report from Saudi Arabia indicated that COVID-19 vaccine acceptance was 68%.Citation17 COVID-19 vaccine hesitancy in Pakistan is understudied in context of demographic factors. We set up this cross-sectional study to assess the demographic factors associated with COVID-19 vaccine acceptance, hesitancy, and refusal among social media users in Pakistan during the COVID-19 lockdown.

Methods

Study setting

This cross-sectional study was conducted during the months of February and March 2021 among residents of Sukkur City. Data was collected from 1 March 2021 to 15 March 2021. Sukkur is the third largest city of Pakistani province Sindh. According to latest census, the population of Sukkur district is 1,488,372. Among this figure, 47.82% are females.Citation18 Among total population, 54.53% people are literate.Citation18 Eighty percent of the population speaks Sindhi language, and 20% of the population speaks Urdu language. The economy of the city depends on agriculture, cement, and other small industries. The socioeconomic problems of the city include low literacy rate, gender discrimination, income inequality, and barriers to access good quality healthcare.Citation19 A pretested online questionnaire consisted of questions about demographic factors, and COVID-19 vaccine was distributed through social media platforms including Facebook, Twitter, WhatsApp, Telegram, and WeChat. Questionnaire was made available in Sindhi and Urdu languages. Snowball sampling strategy was used to collect the data. Participants of the study were asked to refer the same questionnaire to their friends for data collection. Participants were asked about their informed consent on the first page of the online questionnaire. The confidentiality and secrecy of the personal data of study participants was assured. Adults with age ≥18 years and permanent residents of Sukkur District were included in the study. People aged <18 years, newly migrated citizens, and citizens who were not belonging to District Sukkur were excluded from formal data analysis.

Sample size

According to a census conducted by the Government of Pakistan in 2017, the population of Sukkur was 1,488,372.Citation18 By hypothesizing % frequency of outcome factor in the population 50% ±5 at confidence interval 95%, 384 samples were enough to carry out this unmatched cross-sectional study. Open EPI software was used to calculate sample size.Citation20

Sampling

Variable definition

Vaccine hesitancy/refusal is defined as “delay in accepting or refusal of vaccination despite availability of vaccination.”Citation21 Demographic variables included factors such as age in years, gender, living area, monthly income, education, and marital status.

Data analysis

The Excel sheet of data collected online was retrieved. Then, a master Excel sheet was generated. Data was entered and filtered as per inclusion criteria. Then, the Excel sheet was transferred to Special Package for Social Sciences Software (SPSS) version 23 for statistical analysis. Descriptive statistics option was used to calculate the frequencies. Chi-square test was used to associate between two factors and outcomes. p value <.05 was considered as the threshold of significance.

Ethical approval

The study was approved by the Research Ethical Review Committee of University of Sindh, Jamshoro.

Results

Basic demographic characteristics of study participants

The total number of study participants was 479. Among all study participants, 74.3% participants were aged ≤30 years. Among all participants, 55.1% were females. Marital status-wise distribution showed that 69.3% participants were unmarried. The educational profiling of data showed that 19.8% of the participants were educated till ≤12 years, 54.4% of the participants were educated till ≤16 years, and 25.5% of participants were educated till >16 years. Among all participants, 57% were residents of urban areas. Financial profiling shows that 38% of the study participants belonged to low socioeconomic status, 86.6% of study participants belonged to middle socioeconomic status, and 5% of study participants belonged to upper socioeconomic status (). The overall vaccine acceptance was 40.5%, vaccine hesitancy was 29%, and vaccine refusal was 30% among the study participants ().

Table 1. Basic demographic characteristics of study participants

Demographic factors associated with COVID-19 vaccine acceptance

Compared to older people (aged >30 years), prevalence of vaccine acceptance was higher among younger people (aged <30 years) (χ2 = 7.45, p = .02). Compared to females, the prevalence of vaccine acceptance was higher among males (χ2 = 7.45, p = .02). Compared to less educated people (education <12 years), prevalence of vaccine acceptance was higher among more educated people (education >12) (χ2 = 28.68, p < .0001) ().

Table 2. Association of factors associated with willingness to accept vaccine against COVID19

Demographic factors associated with COVID-19 vaccine hesitancy

Compared to younger people (aged <30 years), prevalence of vaccine hesitancy was higher among older people (aged >30 years) (χ2 = 7.45, p = .02) ().

Demographic factors associated with COVID-19 vaccine refusal

Compared to younger people (aged <30 years), prevalence of vaccine refusal was higher among older people (aged >30 years) (χ2 = 7.45, p = .02). Compared to males, the prevalence of vaccine refusal was higher among females (χ2 = 7.45, p = .02). Compared to more educated people (education >12 years), prevalence of vaccine refusal was higher among less educated people (education >12) (χ2 = 28.68, p < .0001) ().

Discussion

Vaccine hesitancy has been identified among one of top 10 threats to global health.Citation22 The ongoing COVID-19 pandemic has a devastating impact on global health with the highest rate of morbidity and mortality among populations. COVID-19 vaccine efficacy varies among different platforms and may have some safety issues.Citation23 Our study showed that overall vaccine acceptance was 40.5%, vaccine hesitancy was 29%, and vaccine refusal was 30% among the study participants. A previously conducted study from Bangladesh has reported 32.5% vaccine hesitancy, which is very close to our result.Citation24 This study showed that married males living in urban areas with low income and educated ≤16 years were hesitant to vaccinate against COVID-19, which is also consistent with the report from Bangladesh that showed hesitancy was higher in males aged >60, without job and low-income profile.Citation24 The vaccine hesitancy and refusal rates vary in different studies.Citation6 Our results showed that the vaccine refusal was 30% and that was higher in females with age >30 who had low income and living in rural areas. A report from Saudi Arabia indicated that vaccine hesitancy and refusal was 46.6% among the general population,Citation25 which is 13% less than that vaccine hesitancy and refusal percentage (60%) of this study. The less hesitancy and refusal will lead to better outcomes of vaccination. Health awareness and education play an important role in vaccine acceptance in Pakistan. Yasmin et al, conducted a study on COVID-19 vaccine acceptance and refusal. They used sample of 1698 participants from entire country. They have reported that 498 participants refused to vaccinate themselves against COVID-19. In refusal group, 69% study participants were females and 47% of participants had education <12 years.Citation26 Our results can also show the same trend. The previously published qualitative study showed the understanding of Pakistani politicians about COVID-19. The study reported that Pakistani politicians and media commentators think that COVID-19 is an effort to target Islamic nations to allow Jews to rule the world and include nanochips in the bodies of people to gain control. Airing of such comments from TV, lack of health education about COVID-19, having low income, and aged are the factors that are associated with the vaccine hesitancy in our report. Vaccine hesitancy and refusal could be a potential barrier to achieve immunization against COVID-19. There is a need to launch an effective COVID-19-related health education program that can propagate the scientific information about the vaccination of COVID-19.

Limitations

Our study has several limitations. Firstly, it was a cross-sectional study that represented the responses of a community at a given time point. It was conducted before when vaccines were not available in Pakistan. Therefore, the figure of COVID-19 vaccine acceptance and hesitancy may have changed with time. Secondly, the study was conducted using an online self-administered questionnaire. This could lead to potential bias in responses compared with face-to-face interview method of data collection. Potential bias in responses could be due to the snowball sampling strategy that involved referring to known people, usually people who are friends or relatives tend to have a similar level of hesitance (peer effect). We adopted this method because during COVID-19 lockdown it was the only available method to collect the data. Thirdly, the study did not assess the reasons behind the vaccine acceptance and hesitancy. We recommend that these factors may be considered in future studies.

Conclusion

COVID-19 vaccine hesitancy and refusal were higher in the general population particularly in elderly people, females, and people with education less than 12 years. There is a need to launch an effective vaccine education program on radio, television, print, and social media to increase knowledge about vaccination so that Pakistan can achieve immunization against COVID-19 among these risk groups.

Authors’ contribution

AAS: ZAL: JV: study design, data analysis, manuscript writing and revisions.

NMB, RBS: GMK: data collection and assembly.

Consent to publish

All authors have read and approved the manuscript.

Acknowledgments

The authors are thankful to the data collection team and study participants who cooperated the data collection.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

References

  • Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity. 2020;109:102433. doi:10.1016/j.jaut.2020.102433.
  • Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery (London, England). 2020;76:71–5. doi:10.1016/j.ijsu.2020.02.034.
  • World Health Organization. WHO Coronavirus (COVID-19) dashboard. 2021 [accessed 2021 May 6]. https://covid19.who.int/.
  • Shrestha N, Shad MY, Ulvi O, Khan MH, Karamehic-Muratovic A, Nguyen USDT, Baghbanzadeh M, Wardrup R, Aghamohammadi N, Cervantes D, et al. The impact of COVID-19 on globalization. One Health (Amsterdam, Netherlands). 2020;11:100180. doi:10.1016/j.onehlt.2020.100180.
  • El-Shitany NA, Harakeh S, Badr-Eldin SM, Bagher AM, Eid B, Almukadi H, Alghamdi BS, Alahmadi AA, Hassan NA, Sindi N, Alghamdi SA. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. Int J Gen Med. 2021;14:1389.
  • Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160. doi:10.3390/vaccines9020160.
  • Razai MS, Osama T, McKechnie DG, Majeed A. Covid-19 vaccine hesitancy among ethnic minority groups. Br Med J Publ Group. 2021. https://doi.org/10.1136/bmj.n513.
  • Grech V, Gauci C, Agius S. Vaccine hesitancy among Maltese healthcare workers toward influenza and novel COVID-19 vaccination. Early Human Development. 2020;105213. doi:10.1016/j.earlhumdev.2020.105213.
  • The SAGE Working Group on Vaccine Hesitancy. Report of the SAGE working group on vaccine hesitancy. 2014.
  • Bhutta ZA, Basnyat B, Saha S, Laxminarayan R. Covid-19 risks and response in South Asia. Br Med J Publ Group. 2020;m1190. doi:10.1136/bmj.m1190.
  • World Health Organization. Polio-free certification of the World Health Organization South-East Asia region. 2021 [accessed 2021 May 3]. https://www.who.int/southeastasia/activities/maintaining-polio-free-status/polio-free-certification-of-the-world-health-organization-south-east-asia-region#:~:text=East%20Asia%20Region-,WHO%20South%2DEast%20Asia%20Region%20is%20officially%20certified%20polio%2Dfree,%2C%20Thailand%20and%20Timor%2DLeste.
  • Khan YH, Mallhi TH, Alotaibi NH, Alzarea AI, Alanazi AS, Tanveer N, Hashmi FK. Threat of COVID-19 vaccine hesitancy in Pakistan: the need for measures to neutralize misleading narratives. The American Journal of Tropical Medicine and Hygiene. 2020;103(2):603–04. doi:10.4269/ajtmh.20-0654.
  • Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis. 2020;14(12):e0008961. doi:10.1371/journal.pntd.0008961.
  • Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020;38(45):7002–06. doi:10.1016/j.vaccine.2020.09.041.
  • Taylor S, Landry CA, Paluszek MM, Groenewoud R, Rachor GS, Asmundson GJ. A proactive approach for managing COVID-19: the importance of understanding the motivational roots of vaccination hesitancy for SARS-CoV2. Front Psycho. 2020;11:2890.
  • Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, Yaseen A, Ababneh NA, Bakri FG, Mahafzah A, et al. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines. 2021;9(1):42. doi:10.3390/vaccines9010042.
  • Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey. J Multidiscip Healthc. 2020;13:1657–63. doi:10.2147/JMDH.S276771.
  • G.O.P Pakistan Bureau of Statistics. Census-2017 - detailed tables Sukkur District. 2021 [accessed 2021 Dec 12]. https://www.pbs.gov.pk/node/3391/?name=082.
  • Jamro B, Junejo AA, Lal S, Bouk GR, Jamro S. Risk factors for severe acute malnutrition in children under the age of five year in Sukkur. Pak J Med Res. 2012;51:4.
  • Dean AG. S.K., Soe MM. OpenEpi: open source epidemiologic statistics for public health. USA; 2013 [accessed 2020 Oct 17]. www.OpenEpi.com.
  • MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.
  • World Health Organization. Ten threats to global health in 2019. 2019 [accessed 2020 May 5]. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.
  • Jayadevan R, Shenoy RS, Anithadevi T. Survey of symptoms following COVID-19 vaccination in India. 2021.
  • Ali M, Hossain A. What is the extent of COVID-19 vaccine hesitancy in Bangladesh?: a cross-sectional rapid national survey. BMJ Open. 2021;11:e050303. doi:10.1136/bmjopen-2021-050303.
  • Almohaithef MA, Padhi BK, Ennaceur SA. Demographics of COVID19 vaccine hesitancy during the second wave of COVID-19 pandemic: a cross-sectional web-based survey in Saudi Arabia. 2021.
  • Yasmin F, Asghar W, Babar MS, Khan H, Ahmad S, Hameed Z, Asghar MS, Nauman H, Khattak AK, Arshad Z, et al. Acceptance rates and beliefs toward COVID-19 vaccination among the general population of Pakistan: a cross-sectional survey. Am J Trop Med Hyg. 2021;105(5):1230–39. doi:10.4269/ajtmh.21-0297.